LBA86 Randomised phase III trial of androgen deprivation therapy (ADT) with radiation therapy with or without enzalutamide for high risk, clinically localised prostate cancer: ENZARAD (ANZUP 1303)
Year: 2025
Type: conference-abstract
Source: Annals of Oncology
Institutions: Harvard University, Mass General Brigham, The University of Adelaide, The University of Sydney, Fiona Stanley Hospital, Auckland City Hospital, Calvary Mater Newcastle Hospital, Royal Prince Alfred Hospital, Princess Alexandra Hospital, GenesisCare, Imperial College Healthcare NHS Trust, Charing Cross Hospital, Royal United Hospital, Royal United Hospital Bath NHS Trust, Paracelsus Medical University, Bon Secours Hospital Cork, Guy's and St Thomas' NHS Foundation Trust, Eastern Health, Monash University, Peter MacCallum Cancer Centre
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
OpenAlex ID: W4416391607